Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis

J Am Acad Dermatol. 2007 Apr;56(4):710-2. doi: 10.1016/j.jaad.2007.01.022. Epub 2007 Feb 7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biopsy, Needle
  • Contrast Media / adverse effects
  • Female
  • Fibrosis / etiology*
  • Fibrosis / pathology
  • Gadolinium DTPA / adverse effects*
  • Humans
  • Immunohistochemistry
  • Kidney / drug effects
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / diagnosis
  • Male
  • Mass Spectrometry
  • Risk Assessment
  • Sampling Studies
  • Sensitivity and Specificity
  • Skin / drug effects

Substances

  • Contrast Media
  • Gadolinium DTPA